SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles
Zhongjin: The contradiction between supply and demand in overseas electricity is prominent, and Chinese manufacturers are welcoming an accelerated period of going global.
EB SECURITIES: How to view February's significantly lower-than-expected non-farm data?
Oracle Corporation (ORCL.US) abandons its plans to expand data centers in Texas, OpenAI or Meta (META.US) may take over the project.
Zhongjin: The contradiction between supply and demand in overseas electricity is prominent, and Chinese manufacturers are welcoming an accelerated period of going global.
EB SECURITIES: How to view February's significantly lower-than-expected non-farm data?
Oracle Corporation (ORCL.US) abandons its plans to expand data centers in Texas, OpenAI or Meta (META.US) may take over the project.
RECOMMEND
